Skip to Content Facebook Feature Image

Elucid Appoints Mark Miller as Chief Revenue Officer to Lead Commercial Expansion Ahead of BioIntegrated FFR-CT Launch

Business

Elucid Appoints Mark Miller as Chief Revenue Officer to Lead Commercial Expansion Ahead of BioIntegrated FFR-CT Launch
Business

Business

Elucid Appoints Mark Miller as Chief Revenue Officer to Lead Commercial Expansion Ahead of BioIntegrated FFR-CT Launch

2026-09-29 19:06 Last Updated At:19:30

BOSTON--(BUSINESS WIRE)--Sep 29, 2026--

Elucid, a medical technology company using AI-powered, clinically validated software to advance precision diagnosis of cardiovascular disease, today announced that Mark Miller has joined the company as chief revenue officer (CRO). Miller will sit on Elucid's leadership team and report directly to CEO Kelly Huang, PhD. He joins the company ahead of the launch of its comprehensive cardiovascular platform, which is comprised of its FDA-cleared Plaque-IQ™ and its BioIntegrated FFR-CT software, pending FDA clearance.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260929806031/en/

Miller has more than 25 years of experience building and scaling sales organizations across cardiovascular imaging, cardiac diagnostics, and AI-enabled clinical decision support, grounded in a clinical foundation in cardiopulmonary science. He spent a decade between GE Healthcare and Philips, selling directly into cardiology practices and electrophysiology labs. Also, Miller served as vice president of sales at Cassling, a regional distribution and solutions partner for Siemens Healthineers, where he held full P&L responsibility across imaging, procedural, and clinical workflow solutions, scaling bookings and leading a commercial team of more than 40 professionals across sales, customer success, revenue operations and solution sales.

"Mark brings a combination of sales leadership, hands-on clinical credibility in our CT cardiology ecosystem, and the repeatable go-to-market agility and discipline we need to scale our commercial momentum upon FDA clearance of our BioIntegrated FFR-CT software," said Elucid CEO Kelly Huang. "This is a big step towards our commercial launch, and I couldn't be more confident in the team we're building to meet the moment."

"Elucid is doing something genuinely rare in this space. It is applying rigorous, histology-validated science to give physicians a clearer picture of cardiovascular risk," said Miller. "Having spent my career on the front lines of the CT cardiology ecosystem, I've seen firsthand how clinicians need better tools to guide treatment decisions. I'm excited to build the commercial engine that gets this technology into the hands of the physicians and patients who need it most."

About Elucid

Elucid is a Boston-based medical technology company that develops AI to see invisible features of cardiovascular risk. The company is dedicated to developing a clinical platform to help physicians deliver CCTA-guided personalized care by providing a more precise view of atherosclerosis, the root cause of cardiovascular disease. The company's FDA-cleared Plaque-IQ™ image analysis software is designed to help physicians prioritize and personalize treatment based on actual disease, rather than population-based risk of disease. Plaque-IQ equips physicians with critical information regarding the type and amount of plaque in arteries that can lead to heart attack and stroke. Elucid is also pursuing an indication for FFR-CT, which helps physicians identify coronary blockages and the extent of a patient's ischemia non-invasively. Elucid’s BioIntegrated FFR-CT software, which integrates anatomy, plaque biology, and physiology, is derived from its plaque algorithm, resulting in concordance with its plaque analysis. For more information, visit elucid.com.

Mark Miller joins Elucid as chief revenue officer ahead of the company's launch of its comprehensive cardiovascular platform, which is comprised of its FDA-cleared Plaque-IQ™ and its BioIntegrated FFR-CT software, pending FDA clearance.

Mark Miller joins Elucid as chief revenue officer ahead of the company's launch of its comprehensive cardiovascular platform, which is comprised of its FDA-cleared Plaque-IQ™ and its BioIntegrated FFR-CT software, pending FDA clearance.

GENEVA (AP) — FIFA lawyers claimed UEFA is harassing Gianni Infantino, in a court filing urging a Florida judge to deny the European soccer body’s request for evidence discovery about a World Cup private investor plan that has rocked the sport.

The 21-page filing to the court in the Southern District of Florida late Monday, and seen by The Associated Press, said UEFA was wrong to suggest the FIFA president sought to profit personally from the project that provoked a furor in July and was dropped within days.

UEFA later asked for authorization of discovery with three courts — including in Manhattan, against Josh Kushner’s New York-based investment firm, and Miami, where FIFA has an office base — aiming to help prepare a criminal complaint against Infantino in Switzerland for financial mismanagement.

“UEFA’s conduct demonstrates that its (court filing) was made in bad faith and for the purpose of harassment,” lawyers for FIFA argue in the document.

The filing also notes the Nov. 18 deadline for potential candidates to enter the FIFA presidential election contest next March in Morocco, where Infantino plans to seek a fourth and final term in office through 2031.

“This court should reject any attempt to influence FIFA’s presidential election based on these grounds,” FIFA lawyers wrote in the filing Monday.

UEFA led a global backlash to the FIFA Forward Enterprise (FFE) plan and is preparing an election challenge to Infantino, who had seemed set to win unopposed until creating the biggest crisis of his near 11-year presidency.

Infantino’s plan was to create the FFE subsidiary and sell at least 20% of nonprofit FIFA’s future commercial rights for $4.2 billion to investors led by Josh Kushner, the brother of U.S. President Donald Trump’s son-in-law Jared Kushner.

UEFA’s court filings one month ago claimed the value was a “fraudulently off-market price promoted by Infantino for his own benefit,” amid speculation he eyed a CEO-like role at the subsidiary on a higher salary than his current $6 million presidential pay package.

FIFA lawyers claimed UEFA “falsely asserts that Mr. Infantino sought to have a personal financial interest in the FFE project.”

The secretive plan was revealed July 28 by media reports and led FIFA’s now-ousted chief operating officer Kevin Lamour to criticize Infantino’s leadership. The FIFA boss’s senior adviser Carlos Cordeiro, a former Goldman Sachs partner, also resigned in protest at the deal he said was bad for soccer.

Infantino later apologized for errors in how the sell-off plan was handled, and has since offered to open an independent external review of the soccer body’s governance.

FIFA has consistently said the commercial spinoff was intended to accelerate development of soccer worldwide, outside the wealthy power base of Europe.

In a separate development Monday, Infantino wrote to the 211 member federations of FIFA accepting it could pay them more from cash reserves.

That follows a call this month by Infantino’s critics at UEFA, North American soccer body CONCACAF and the Asian Football Confederation that FIFA can afford to pay each of the 211 members a $10 million dividend from its cash reserves of about $6 billion.

Infantino had offered each member $20 million, from the intended $4.2 billion investment by Kushner and others, pending a mid-September deadline to approve the FFE project.

An Oct. 15 meeting of the 37-member FIFA Council, to be chaired by Infantino in Zurich, is set to debate proposals on finance and governance as he seeks to manage fallout from the divisive World Cup sell-off plan.

See AP’s full soccer coverage here

FIFA President Gianni Infantino poses for photos with volunteers after the Women's U20 World Cup final soccer match between Spain and North Korea in Lodz, Poland, Sunday, Sept. 27, 2026. (AP Photo/Beata Zawrzel)

FIFA President Gianni Infantino poses for photos with volunteers after the Women's U20 World Cup final soccer match between Spain and North Korea in Lodz, Poland, Sunday, Sept. 27, 2026. (AP Photo/Beata Zawrzel)

FIFA President Gianni Infantino attends the Women's U20 World Cup final soccer match between Spain and North Korea in Lodz, Poland, Sunday, Sept. 27, 2026. (AP Photo/Beata Zawrzel)

FIFA President Gianni Infantino attends the Women's U20 World Cup final soccer match between Spain and North Korea in Lodz, Poland, Sunday, Sept. 27, 2026. (AP Photo/Beata Zawrzel)

Recommended Articles